Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Report Guidance | 5 | 1 |
| Clinical Trials by Region | 6 | 9 |
| Clinical Trials and Average Enrollment by Country | 7 | 3 |
| Top Five Countries Contributing to Clinical Trials in Asia-Pacific | 10 | 1 |
| Top Five Countries Contributing to Clinical Trials in Europe | 11 | 1 |
| Top Countries Contributing to Clinical Trials in North America | 12 | 1 |
| Top Five Countries Contributing to Clinical Trials in Middle East and Africa | 13 | 1 |
| Top Five Countries Contributing to Clinical Trials in Central and South America | 14 | 1 |
| Clinical Trials by G7 Countries: Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials | 15 | 2 |
| Clinical Trials by Phase in G7 Countries | 17 | 1 |
| Clinical Trials in G7 Countries by Trial Status | 18 | 1 |
| Clinical Trials by E7 Countries: Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials | 19 | 2 |
| Clinical Trials by Phase in E7 Countries | 21 | 1 |
| Clinical Trials in E7 Countries by Trial Status | 22 | 1 |
| Clinical Trials by Phase | 23 | 2 |
| In Progress Trials by Phase | 24 | 1 |
| Clinical Trials by Trial Status | 25 | 1 |
| Clinical Trials by End Point Status | 26 | 1 |
| Subjects Recruited Over a Period of Time | 27 | 1 |
| Clinical Trials by Sponsor Type | 28 | 1 |
| Prominent Sponsors | 29 | 3 |
| Top Companies Participating in Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials | 30 | 2 |
| Prominent Drugs | 32 | 1 |
| Latest Clinical Trials News on Human Immunodeficiency Virus (HIV) Infections (AIDS) | 33 | 3 |
| Oct 06, 2016: CytoDyn Announces Favorable Protocol Modifications for Pivotal Phase 3 Combination Trial With PRO 140 After Positive FDA Meeting | 33 | 1 |
| Sep 13, 2016: ABIVAX Completes the Second Milestone in CaReNa, a Strategic Industrial Innovation Project Supported by Bpifrance | 33 | 1 |
| Aug 23, 2016: Patients Approach Two Years of Complete HIV Viral Load Suppression in Phase 2b PRO 140 Monotherapy Extension Study | 34 | 1 |
| Aug 18, 2016: Ibalizumab Phase III Study Primary End-Point Results to Be Presented at IDWeek 2016 | 35 | 1 |
| Aug 16, 2016: ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment | 35 | 1 |
| Jul 26, 2016: SMILE Trial Launch investigating a potentially lower toxicity, simplified treatment regimen for HIV infected children | 35 | 1 |
| Clinical Trial Profile Snapshots | 36 | 2758 |
| Appendix | 2794 | 3 |
| Abbreviations | 2794 | 1 |
| Definitions | 2794 | 1 |
| Research Methodology | 2795 | 1 |
| Secondary Research | 2795 | 1 |
| About GlobalData | 2796 | 1 |
| Contact Us | 2796 | 1 |
| Disclaimer | 2796 | 1 |
| Source | 2797 | 1 |
